Literature DB >> 27587635

The Epi Info Viral Hemorrhagic Fever (VHF) Application: A Resource for Outbreak Data Management and Contact Tracing in the 2014-2016 West Africa Ebola Epidemic.

Ilana J Schafer1, Erik Knudsen2, Lucy A McNamara3, Sachin Agnihotri2, Pierre E Rollin4, Asad Islam2.   

Abstract

The Epi Info Viral Hemorrhagic Fever application (Epi Info VHF) was developed in response to challenges managing outbreak data during four 2012 filovirus outbreaks. Development goals included combining case and contact data in a relational database, facilitating data-driven contact tracing, and improving outbreak data consistency and use. The application was first deployed in Guinea, when the West Africa Ebola epidemic was detected, in March 2014, and has been used in 7 African countries and 2 US states. Epi Info VHF enabled reporting of compatible data from multiple countries, contributing to international Ebola knowledge. However, challenges were encountered in accommodating the epidemic's unexpectedly large magnitude, addressing country-specific needs within 1 software product, and using the application in settings with limited Internet access and information technology support. Use of Epi Info VHF in the West Africa Ebola epidemic highlighted the fundamental importance of good data management for effective outbreak response, regardless of the software used. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Ebola; contact tracing; data management; outbreak; software; viral hemorrhagic fever

Mesh:

Year:  2016        PMID: 27587635     DOI: 10.1093/infdis/jiw272

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Impact of enhanced viral haemorrhagic fever surveillance on outbreak detection and response in Uganda.

Authors:  Trevor R Shoemaker; Stephen Balinandi; Alex Tumusiime; Luke Nyakarahuka; Julius Lutwama; Edward Mbidde; Aaron Kofman; John D Klena; Ute Ströher; Pierre E Rollin; Stuart T Nichol
Journal:  Lancet Infect Dis       Date:  2018-03-21       Impact factor: 25.071

2.  Contact tracing performance during the Ebola virus disease outbreak in Kenema district, Sierra Leone.

Authors:  Mikiko Senga; Alpha Koi; Lina Moses; Nadia Wauquier; Philippe Barboza; Maria Dolores Fernandez-Garcia; Etsub Engedashet; Fredson Kuti-George; Aychiluhim Damtew Mitiku; Mohamed Vandi; David Kargbo; Pierre Formenty; Stephane Hugonnet; Eric Bertherat; Christopher Lane
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-26       Impact factor: 6.237

3.  Sensitivity and Specificity of Suspected Case Definition Used during West Africa Ebola Epidemic.

Authors:  Christopher H Hsu; Steven W Champaloux; Sakoba Keïta; Lise Martel; Pepe Bilivogui; Barbara Knust; Andrea M McCollum
Journal:  Emerg Infect Dis       Date:  2018-01       Impact factor: 6.883

4.  Analysis of patient data from laboratories during the Ebola virus disease outbreak in Liberia, April 2014 to March 2015.

Authors:  Yuki Furuse; Mosoka Fallah; Hitoshi Oshitani; Ling Kituyi; Nuha Mahmoud; Emmanuel Musa; Alex Gasasira; Tolbert Nyenswah; Bernice Dahn; Luke Bawo
Journal:  PLoS Negl Trop Dis       Date:  2017-07-21

Review 5.  Key data for outbreak evaluation: building on the Ebola experience.

Authors:  Anne Cori; Christl A Donnelly; Ilaria Dorigatti; Neil M Ferguson; Christophe Fraser; Tini Garske; Thibaut Jombart; Gemma Nedjati-Gilani; Pierre Nouvellet; Steven Riley; Maria D Van Kerkhove; Harriet L Mills; Isobel M Blake
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-26       Impact factor: 6.237

6.  Improving health information systems during an emergency: lessons and recommendations from an Ebola treatment centre in Sierra Leone.

Authors:  Shefali Oza; Kevin Wing; Alieu Amara Sesay; Sabah Boufkhed; Catherine Houlihan; Lahai Vandi; Sahr Charles Sebba; Catherine R McGowan; Rachael Cummings; Francesco Checchi
Journal:  BMC Med Inform Decis Mak       Date:  2019-05-27       Impact factor: 2.796

7.  Marburg virus disease outbreak in Kween District Uganda, 2017: Epidemiological and laboratory findings.

Authors:  Luke Nyakarahuka; Trevor R Shoemaker; Stephen Balinandi; Godfrey Chemos; Benon Kwesiga; Sophia Mulei; Jackson Kyondo; Alex Tumusiime; Aaron Kofman; Ben Masiira; Shannon Whitmer; Shelley Brown; Debi Cannon; Cheng-Feng Chiang; James Graziano; Maria Morales-Betoulle; Ketan Patel; Sara Zufan; Innocent Komakech; Nasan Natseri; Philip Musobo Chepkwurui; Bernard Lubwama; Jude Okiria; Joshua Kayiwa; Innocent H Nkonwa; Patricia Eyu; Lydia Nakiire; Edward Chelangat Okarikod; Leonard Cheptoyek; Barasa Emmanuel Wangila; Michael Wanje; Patrick Tusiime; Lilian Bulage; Henry G Mwebesa; Alex R Ario; Issa Makumbi; Anne Nakinsige; Allan Muruta; Miriam Nanyunja; Jaco Homsy; Bao-Ping Zhu; Lisa Nelson; Pontiano Kaleebu; Pierre E Rollin; Stuart T Nichol; John D Klena; Julius J Lutwama
Journal:  PLoS Negl Trop Dis       Date:  2019-03-18

Review 8.  GoCoronaGo: Privacy Respecting Contact Tracing for COVID-19 Management.

Authors:  Yogesh Simmhan; Tarun Rambha; Aakash Khochare; Shriram Ramesh; Animesh Baranawal; John Varghese George; Rahul Atul Bhope; Amrita Namtirtha; Amritha Sundararajan; Sharath Suresh Bhargav; Nihar Thakkar; Raj Kiran
Journal:  J Indian Inst Sci       Date:  2020-11-11

9.  Isolated Case of Marburg Virus Disease, Kampala, Uganda, 2014.

Authors:  Luke Nyakarahuka; Joseph Ojwang; Alex Tumusiime; Stephen Balinandi; Shannon Whitmer; Simon Kyazze; Sam Kasozi; Milton Wetaka; Issa Makumbi; Melissa Dahlke; Jeff Borchert; Julius Lutwama; Ute Ströher; Pierre E Rollin; Stuart T Nichol; Trevor R Shoemaker
Journal:  Emerg Infect Dis       Date:  2017-06       Impact factor: 6.883

Review 10.  Precision Global Health - The case of Ebola: a scoping review.

Authors:  Nefti-Eboni Bempong; Rafael Ruiz De Castañeda; Stefanie Schütte; Isabelle Bolon; Olivia Keiser; Gérard Escher; Antoine Flahault
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.